Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-19 · accession 0001323212-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-23 | 2025-12-19 | PTCT | Pauwels Eric | Chief BUSINESS Off | S - Sale+OE | $77.26 | -20.5K | 88.7K | -19% | -$1.58M |
| DM | 2025-12-23 | 2025-12-19 | PTCT | Pauwels Eric | Chief BUSINESS Off | M - OptEx | $65.15 | +20.5K | 90.2K | +29% | +$1.34M |
| DM | 2025-12-23 | 2025-12-19 | PTCT | Pauwels Eric | Chief BUSINESS Off | M - OptEx | $0.00 | -20.5K | 19.8K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-19 | S | D | 193 | $75.45 | 70,745 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.04 to $75.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-12-19 | S | D | 3,220 | $78.33 | 70,373 | D | — | — | (F11) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.13 to $78.56 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-12-19 | S | D | 10,548 | $77.55 | 73,593 | D | — | — | (F10) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.10 to $78.02 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-12-19 | S | D | 4,537 | $76.33 | 84,141 | D | — | — | (F9) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.05 to $76.77 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-12-19 | M | A | 138 | $66.49 | 70,511 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-19 | S | D | 37 | $75.66 | 70,474 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.20 to $76.08 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2025-12-19 | S | D | 42 | $77.26 | 70,432 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.60 to $77.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2025-12-19 | S | D | 59 | $78.01 | 70,373 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.65 to $78.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2025-12-19 | M | A | 565 | $18.01 | 70,938 | D | — | — | |
| 10 | Common | Common Stock | 2025-12-19 | S | D | 313 | $77.73 | 70,432 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.25 to $78.22 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 11 | Common | Common Stock | 2025-12-19 | S | D | 59 | $78.43 | 70,373 | D | — | — | (F7) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.34 to $78.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 12 | Common | Common Stock | 2025-12-19 | M | A | 19,805 | $66.49 | 90,178 | D | — | — | |
| 13 | Common | Common Stock | 2025-12-19 | S | D | 1,500 | $75.77 | 88,678 | D | — | — | (F8) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.05 to $76.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 14 | Derivative | Stock Option (Right to Buy) | 2025-12-19 | M | D | 19,805 | $0.00 | 0 | D | $66.49 · — to 2031-01-05 | 19,805 Common Stock | (F12) Currently exercisable. |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-12-19 | M | D | 565 | $0.00 | 17,566 | D | $18.01 · — to 2028-01-02 | 565 Common Stock | (F12) Currently exercisable. |
| 16 | Derivative | Stock Option (Right to Buy) | 2025-12-19 | M | D | 138 | $0.00 | 19,805 | D | $66.49 · — to 2031-01-05 | 138 Common Stock | (F12) Currently exercisable. |